ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results

2026-11-05

READ MORE >

ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

2026-11-05

READ MORE >

NASDAQ - ANIP

$68.95

-0.67 (-0.96%)

Pricing delayed by 20 minutes
Last updated 2026-11-06 11:26:00